Evidence map›Paper›PMID 39627726›Full record

Observational studyBMC public health2024

Implementation of the advanced HIV disease package of care using a public health approach: lessons from Nigeria.

Williams Eigege, Oche Agbaji, Nere Otubu, Opeyemi Abudiore, Oluwakemi Sowale, Boma Levy-Braide, Asari Inyang, Dinesh Rathakrishnan, Ikechukwu Amamilo, James Conroy and 11 more

Abstract readObservational Study
In one paragraph

Observational study in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Williams EigegeClinton Health Access Initiative, Abuja, Nigeria. weigege@clintonhealthaccess.org.
Oche AgbajiDepartment of Internal Medicine, Jos University Teaching Hospital, Jos, Nigeria.
Nere OtubuClinton Health Access Initiative, Abuja, Nigeria.
Opeyemi AbudioreClinton Health Access Initiative, Abuja, Nigeria.
Oluwakemi SowaleClinton Health Access Initiative, Abuja, Nigeria.
Boma Levy-BraideClinton Health Access Initiative, Abuja, Nigeria.
Asari InyangClinton Health Access Initiative, Abuja, Nigeria.
Dinesh RathakrishnanClinton Health Access Initiative, Abuja, Nigeria.
Ikechukwu AmamiloClinton Health Access Initiative, Abuja, Nigeria.
James ConroyClinton Health Access Initiative, Abuja, Nigeria.
Folu LufadejuClinton Health Access Initiative, Abuja, Nigeria.
Carolyn AmoleClinton Health Access Initiative, Abuja, Nigeria.
Owens WiwaClinton Health Access Initiative, Abuja, Nigeria.
Dennis OnotuUS Centres for Disease Control and Prevention, Abuja, Nigeria.
Khalil SanniNational AIDS and STI Control Programme, Federal Ministry of Health, Abuja, Nigeria.
Peter NwaokenneyaNational AIDS and STI Control Programme, Federal Ministry of Health, Abuja, Nigeria.
Mohammed PatikoNational AIDS and STI Control Programme, Federal Ministry of Health, Abuja, Nigeria.
Akudo IkpeazuNational AIDS and STI Control Programme, Federal Ministry of Health, Abuja, Nigeria.
Stephen OgucheDepartment of Internal Medicine, Jos University Teaching Hospital, Jos, Nigeria.
Rita OladeleDepartment of Microbiology, Lagos University Teaching Hospital, Lagos, Nigeria.
Sulaimon AkanmuDepartment of Haematology, Lagos University Teaching Hospital, Lagos, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNigeria adapted the WHO package of care for Advanced HIV Disease (AHD) in 2020. The package includes CD4 + cell count testing to identify People Living with HIV (PLHIV) with AHD, screening and treatment of opportunistic infections, rapid antiretrovirals (ART) initiation, and intensive adherence follow-up. The national program adopted a phased approach in the rollout of the AHD package of care to learn lessons from a few representative health facilities before scaling up across the country. This study describes the process and lessons learned from the first phase of implementation.

methodsThis was a prospective observational study, and participants were enrolled between February and September 2021. Healthcare-worker (HCW) capacity was built to implement the AHD package of care. The study population included newly diagnosed PLHIV ≥ 10 years presenting to care in 28 selected facilities across 4 states in Nigeria. Eligible participants received CD4 + cell testing at baseline. Those with CD4 + cell count < 200 cells/mm

resultsA total of 6,781 patients were enrolled; 71% (4,812) received CD4 + cell count test, of which 41% (1,969 of 4812) had a CD4 + count < 200 cells/mm

conclusionImplementation of the AHD package of care in Nigeria has improved the diagnosis of TB and CM, and will potentially enhance the quality of care for PLHIV if sustained. Findings from this implementation were used to guide national scale-up.

Indexed as

HIV InfectionsAdolescentAdultAIDS-Related Opportunistic InfectionsAnti-Retroviral AgentsCD4 Lymphocyte CountFemaleHumansMaleMiddle AgedNigeriaProspective StudiesPublic HealthYoung AdultAnti-Retroviral AgentsAdvanced HIV Disease (AHD)Antiretroviral Therapy (ART)CD4+Cryptococcal meningitisPeople Living with HIV (PLHIV)Tuberculosis

Identifiers

PMID39627726
PMCPMC11613670

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.